Home The Word Brain My Amedeo FAQ Privacy About   


Amedeo C49

English + 你好 (nǐ hǎo) = limitless possibilities.
Start learning Mandarin Chinese today—for free, forever.

Amedeo C49 is completely free, for life. Next week: +49.


  Neoplasms of the CNS

  Free Subscription


06.10.2025

1 Acta Neuropathol
1 AJNR Am J Neuroradiol
1 Arch Pathol Lab Med
9 BMC Cancer
2 BMC Neurol
1 Br J Cancer
1 Cancer
1 Cancer Res
3 Childs Nerv Syst
1 Eur J Cancer
1 Int J Cancer
2 Int J Radiat Oncol Biol Phys
6 J Neurooncol
4 J Neurosurg
1 J Nucl Med
2 Neuro Oncol
1 Neuroradiology
3 Neurosurgery
1 Pediatr Neurosurg
1 PLoS One
1 Radiol Imaging Cancer


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Acta Neuropathol

  1. JURGENSEN L, Benfatto S, Schmid S, Daenekas B, et al
    In silico purification improves DNA methylation-based classification rates of pediatric low-grade gliomas.
    Acta Neuropathol. 2025;150:34.
    PubMed         Abstract available


    AJNR Am J Neuroradiol

  2. CHEE K, Mirsky DM, Neuberger I, Dastagirzada Y, et al
    Accuracy of Tumor Surveillance of Pediatric Adamantinomatous Craniopharyngioma Using Noncontrast Brain MRI.
    AJNR Am J Neuroradiol. 2025 Sep 25. doi: 10.3174/ajnr.A8928.
    PubMed         Abstract available


    Arch Pathol Lab Med

  3. RUDOLF MA, Ferris SP
    High-Grade Astrocytoma With Piloid Features: Case Series and Review of a Recently Described Brain Tumor Entity.
    Arch Pathol Lab Med. 2025;149:e323-e328.
    PubMed         Abstract available


    BMC Cancer

  4. LI Y, Xu W, Zhao C, Zhang J, et al
    Survival risk stratification of 2021 WHO glioblastoma by MRI radiomics and biological exploration.
    BMC Cancer. 2025;25:1505.
    PubMed         Abstract available

  5. YANG Q, Wang Y, Wu J, Hu H, et al
    Preoperative prediction of pituitary neuroendocrine tumor consistency based on multiparametric MRI radiomics: a multicenter study.
    BMC Cancer. 2025;25:1501.
    PubMed         Abstract available

  6. LEISS SM, Wiestler B, Hou HX, Schmottermeyer D, et al
    Comorbidity burden in elderly high-grade glioma patients: impact on radiotherapy outcomes.
    BMC Cancer. 2025;25:1496.
    PubMed         Abstract available

  7. CHEN X, Xiao X, Wang M, Mei T, et al
    Development and validation of a dynamic nomogram for predicting brain metastasis in stage III NSCLC patients undergoing definitive chemoradiotherapy.
    BMC Cancer. 2025;25:1500.
    PubMed         Abstract available

  8. VARGHESE D, Collins J, Nordstrom B, Miranda M, et al
    Epidemiology and outcomes associated with brain metastases among patients with metastatic breast cancer - a cohort study in US electronic health record data.
    BMC Cancer. 2025;25:1475.
    PubMed         Abstract available

  9. PASYAR N, Rambod M, Zareinezhad S, Soltani A, et al
    The mediation role of hope and social support in the relationship between fatigue and burden in caregivers of patients with brain tumor.
    BMC Cancer. 2025;25:1491.
    PubMed         Abstract available

  10. YANG Z, Dou Z, Wang H, Hu Z, et al
    POLD3 knockdown effects on low-grade glioma: insights from bioinformatics and experimental validation.
    BMC Cancer. 2025;25:1489.
    PubMed         Abstract available

  11. DURRANI S, Al-Ghamdi AA, Al-Bugawi A, Al-Khammash A, et al
    Prognostic factors and survival outcome of brain metastases in breast cancer patients: a retrospective analysis.
    BMC Cancer. 2025;25:1455.
    PubMed         Abstract available

  12. WOJNICKI K, Wojtas B, Ciechomska IA, Kaza B, et al
    Shared and non-overlapping functions of RECQL4 and BLM helicases in chemotherapeutics-induced glioma cell responses.
    BMC Cancer. 2025;25:1434.
    PubMed         Abstract available


    BMC Neurol

  13. IGUCHI T, Furuya T, Koinuma T, Nakajima A, et al
    Lymphomatosis cerebri presenting with rapidly progressive parkinsonism and Holmes tremor: a case report.
    BMC Neurol. 2025;25:392.
    PubMed         Abstract available

  14. JIANG Z, Zhu Z, Tao Z, Niu F, et al
    Primary intracranial plasmablastic lymphoma with intradural extramedullary metastasis: a case report.
    BMC Neurol. 2025;25:394.
    PubMed         Abstract available


    Br J Cancer

  15. SAJWAN R, Wang L, Casar-Borota O, Karakostis K, et al
    A cancer-associated TP53 synonymous mutation induces synthesis of the p53 isoform p53/47.
    Br J Cancer. 2025;133:970-975.
    PubMed         Abstract available


    Cancer

  16. WALSH KM
    Counting what counts: Registry completeness and the epidemiology of nonmalignant meningioma.
    Cancer. 2025;131:e70100.
    PubMed        


    Cancer Res

  17. KIM KW, Choi HJ, Lee JH
    White matter injury fuels early progression of glioblastoma.
    Cancer Res. 2025 Oct 1. doi: 10.1158/0008-5472.CAN-25-4362.
    PubMed         Abstract available


    Childs Nerv Syst

  18. WANG S, Yang K, Hu X, He J, et al
    Fusion of habitat analysis and deep learning on contrast-enhanced T1-weighted imaging for predicting Ki-67 status in pediatric brain tumors.
    Childs Nerv Syst. 2025;41:296.
    PubMed         Abstract available

  19. SUTANTO R, Muchtar YM, Bramantya IN, Haezer RE, et al
    Prenatal MRI diagnosis and postnatal management of interhemispheric cysts associated with corpus callosum dysgenesis: case series and systematic review.
    Childs Nerv Syst. 2025;41:291.
    PubMed         Abstract available

  20. OZTURK O, Kuzucu P, Borcek AO
    Giant intracranial teratoma in a pediatric patient: a case report and literature review.
    Childs Nerv Syst. 2025;41:292.
    PubMed         Abstract available


    Eur J Cancer

  21. VAN LINDER BMH, Brandsma D, Verhoeven E, Jongejan L, et al
    Improving the diagnosis of leptomeningeal metastases by molecular profiling of cell-free DNA from cerebrospinal fluid.
    Eur J Cancer. 2025;229:115783.
    PubMed         Abstract available


    Int J Cancer

  22. HONIKL LS, Kelm A, Krieg SM, Meyer B, et al
    Prospective inter-individual analysis of quality-adjusted life years (QALYs) in brain tumor patients: A comprehensive assessment of health preferences.
    Int J Cancer. 2025 Sep 25. doi: 10.1002/ijc.70171.
    PubMed         Abstract available


    Int J Radiat Oncol Biol Phys

  23. REITMAN ZJ, Fan Y
    Authors' View-FLASH Radiation: A Game-Changer in Pediatric Brain Tumor Treatment?
    Int J Radiat Oncol Biol Phys. 2025;123:848-851.
    PubMed        

  24. MEHTA MP, Gondi V, Ahluwalia MS, Roberge D, et al
    Tumor Treating Fields (TTFields) therapy after stereotactic radiosurgery for brain metastases from non-small cell lung cancer: final results of the phase 3 METIS study.
    Int J Radiat Oncol Biol Phys. 2025 Sep 29:S0360-3016(25)06217.
    PubMed         Abstract available


    J Neurooncol

  25. TINI P, Donnini F, Marampon F, Pastina P, et al
    Timing matters: overall treatment time, radiotherapy interruptions, and outcomes in glioblastomas-prognostic significance in different biological sub-groups.
    J Neurooncol. 2025 Sep 25. doi: 10.1007/s11060-025-05215.
    PubMed         Abstract available

  26. PEDERSEN V, Knudsen AM, Michaelsen SR, Dahlrot RH, et al
    Tumor and immune cell distribution in the tumor core and outer part of glioblastoma, IDH wildtype.
    J Neurooncol. 2025 Sep 25. doi: 10.1007/s11060-025-05232.
    PubMed         Abstract available

  27. DIAZ LS, Agrup M, Asklid A, Embring A, et al
    Correction to: Acute side effects of proton and photon radiotherapy for medulloblastoma: a retrospective national multicenter study.
    J Neurooncol. 2025 Sep 29. doi: 10.1007/s11060-025-05235.
    PubMed        

  28. AN X, Wang J, Yuan J, Zhou X, et al
    Prognostic value of temporal muscle thickness in pediatric medulloblastoma patients aged 3-12 years.
    J Neurooncol. 2025 Sep 29. doi: 10.1007/s11060-025-05229.
    PubMed         Abstract available

  29. SHIBAHARA I, Kumabe T
    Comment on: "Anatomical distribution and prognostic heterogeneity in glioma: unique clinical features of occipital glioblastoma".
    J Neurooncol. 2025 Sep 30. doi: 10.1007/s11060-025-05226.
    PubMed         Abstract available

  30. KHATRI VM, Mestres-Villanueva MA, Daniel S, Yarlagadda S, et al
    Sacituzumab govitecan and stereotactic radiosurgery in the management of HER2 negative breast cancer brain metastases: a multi-institutional report.
    J Neurooncol. 2025 Sep 30. doi: 10.1007/s11060-025-05230.
    PubMed         Abstract available


    J Neurosurg

  31. KARSY M, Kshettry VR, Evans JJ, Barkhoudarian G, et al
    Outcome metrics for primary endoscopic endonasal surgery for low-risk patients with Cushing's disease: an evidence-based position statement from the Registry of Adenomas of the Pituitary and Related Disorders consortium.
    J Neurosurg. 2025;143:907-915.
    PubMed         Abstract available

  32. RYCHEN J, Xu Y, Agostini L, Constanzo F, et al
    The carotidoclinoidal ligament in endoscopic endonasal transcavernous surgery: anatomical variations, operative techniques, and case series.
    J Neurosurg. 2025;143:916-927.
    PubMed         Abstract available

  33. CONSTANZO F, Rychen J, Lee CK, Decker JH, et al
    Patterns of invasion of the medial wall of the cavernous sinus by pituitary adenomas.
    J Neurosurg. 2025;143:895-906.
    PubMed         Abstract available

  34. GAUDEN AJ, Choi JL, Luo I, Han SS, et al
    Outcomes of brainstem cavernous malformation resection, without and with use of a flexible omnidirectional carbon dioxide laser: a single-surgeon series of 277 surgical procedures.
    J Neurosurg. 2025 Jun 27:1-8. doi: 10.3171/2025.3.JNS242848.
    PubMed         Abstract available


    J Nucl Med

  35. FLAUS A, Levigoureux E, Haesebaert J, Briet C, et al
    Prospective Multicenter Evaluation of [(11)C]Methionine PET/MRI Sensitivity Compared with MRI for Localizing Small Pituitary Neuroendocrine Tumor or Pituitary Adenoma in Cushing Disease.
    J Nucl Med. 2025 Aug 21:jnumed.124.269392. doi: 10.2967/jnumed.124.269392.
    PubMed         Abstract available


    Neuro Oncol

  36. ALI H, Zhou N, Chen L, van Hijfte L, et al
    YBX1&YBX3 as novel targets to potentiate immune checkpoint blockade response in gliomas.
    Neuro Oncol. 2025 Sep 30:noaf227. doi: 10.1093.
    PubMed         Abstract available

  37. KANG G, Leary SES, Onar-Thomas A, Li Y, et al
    Response to: Bayesian Reappraisal of ACNS0332 and ACNS0334 Strengthens Subgroup Treatment Effects in High-Risk Pediatric Group 3 Medulloblastoma.
    Neuro Oncol. 2025 Sep 29:noaf212. doi: 10.1093.
    PubMed        


    Neuroradiology

  38. TATOGLU MT, Atalay B
    Incidental detection of anterior clinoid meningioma on [(6)(8)Ga]Ga-DOTATATE PET/CT in a patient with suspected neuroendocrine tumor.
    Neuroradiology. 2025 Sep 30. doi: 10.1007/s00234-025-03788.
    PubMed         Abstract available


    Neurosurgery

  39. WEI CZ, Shanahan RM, Scanlon S, Ozcinar KK, et al
    Primary Versus Salvage Stereotactic Radiosurgery for Patients With Olfactory Groove Meningiomas: A 35-Year Single-Institution Experience.
    Neurosurgery. 2025 Sep 29. doi: 10.1227/neu.0000000000003759.
    PubMed         Abstract available

  40. CHOLAYIL S, Harshil Sai V, Shankar V
    Letter: Stereotactic Radiosurgery Dose Reduction for Melanoma Brain Metastases Patients on Immunotherapy or Target Therapy: A Single-Center Experience.
    Neurosurgery. 2025 Sep 30. doi: 10.1227/neu.0000000000003795.
    PubMed        

  41. TOS SM, Mantziaris G, Sheehan JP
    In Reply: Stereotactic Radiosurgery Dose Reduction for Melanoma Brain Metastases Patients on Immunotherapy or Targeted Therapy: A Single-Center Experience.
    Neurosurgery. 2025 Sep 30. doi: 10.1227/neu.0000000000003796.
    PubMed        


    Pediatr Neurosurg

  42. NGUYEN A, Michel M, Shahrestani S, Boyke A, et al
    Utility of Combining Frailty and Comorbid Disease Indices to Better Predict Outcomes Following Craniotomy for Pediatric Primary Brain Tumors.
    Pediatr Neurosurg. 2025 Oct 3:1-16. doi: 10.1159/000548771.
    PubMed         Abstract available


    PLoS One

  43. MUSTAFOV D, Siddiqui SS, Ahmad I, Charlton J, et al
    New chalcone compound exhibits microrna-mediated anticancer properties in glioblastoma.
    PLoS One. 2025;20:e0330624.
    PubMed         Abstract available


    Radiol Imaging Cancer

  44. CHEN Y, Xiao J, Cen S, Hu Z, et al
    Multiparametric Dynamic Contrast Imaging for Voxelwise Quantitative Assessment of Brain Tumors.
    Radiol Imaging Cancer. 2025;7:e250049.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Neoplasms of the CNS is free of charge.